Anna Emde
Impact in
- Rehabilitation top 10%
- Magnolia and Illicium research
-
- MicroRNA in disease regulation
Papers in
- Oncology 13
- HER2/EGFR in Cancer Research 6
- Cancer Cells and Metastasis 3
- Cancer-related Molecular Pathways 2
- Cancer Treatment and Pharmacology 2
-
- Breast Cancer Treatment Studies 3
- Co-authors
- Eran Hornstein (4 shared papers)Yosef Yarden (4 shared papers)Wolfgang J. Köstler (2 shared papers)Kurt Possinger (3 shared papers)Jan Eucker (1 shared paper)Elena Elstner (1 shared paper)Hongyu Liu (1 shared paper)Carsten‐Oliver Schulz (1 shared paper)
- Journals
- The EMBO Journal (2 papers)Oncogene (2 papers)Clinical Breast Cancer (1 paper)Neoplasia (1 paper)Future Oncology (1 paper)
- Partner nations
- United StatesIsraelGermany
In The Last Decade
Anna Emde
14 papers receiving 598 citations
Peers
Comparison fields: 5 of 78
- Rehabilitation 67
- Cancer Research 137
- Genetics 86
- Neurology 101
- Molecular Biology 331
Countries citing papers authored by Anna Emde
This map shows the geographic impact of Anna Emde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Emde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Emde more than expected).
Fields of papers citing papers by Anna Emde
This network shows the impact of papers produced by Anna Emde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Emde. The network helps show where Anna Emde may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Emde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 172 | |
| 2 | 2008 | 114 | |
| 3 | 2014 | 95 | |
| 4 | 2005 | 76 | |
| 5 | 2010 | 47 | |
| 6 | 2011 | 33 | |
| 7 | 2011 | 20 | |
| 8 | 2010 | 17 | |
| 9 | 2015 | 11 | |
| 10 | 2023 | 11 | |
| 11 | 2020 | 6 | |
| 12 | 2024 | 3 | |
| 13 | Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance. | 2011 | 1 |
| 14 | 2024 | 1 | |
| 15 | 2016 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Anna Emde
Anna Emde is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Molecular Biology, having authored 18 papers that have together received 607 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (6 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer-related Molecular Pathways (2 papers), Amyotrophic Lateral Sclerosis Research (2 papers) and Cancer Treatment and Pharmacology (2 papers). The work is most often cited by research in Rehabilitation (67 citations), Cancer Research (137 citations), Genetics (86 citations), Neurology (101 citations) and Molecular Biology (331 citations). Anna Emde has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include Eran Hornstein, Yosef Yarden, Wolfgang J. Köstler, Kurt Possinger, Jan Eucker, Elena Elstner, Hongyu Liu, Carsten‐Oliver Schulz, Chuanbing Zang and Andrea Kühnl. Their work appears in journals such as The EMBO Journal, Oncogene, Clinical Breast Cancer, Neoplasia and Future Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.